levothyroxine sodium

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 50090-4799
  • Package NDC 50090-4799-0
  • Package NDC 50090-4799-1
  • Application number NDA021116
  • SPL ID f2ee3fc5-4e2b-4b13-bd7c-7cbbf520ac1f
  • SPL set ID 8f7dc71e-4a48-4ba5-945b-f340ff51636e
  • UNII 9J765S329G
  • RxCUI 966224

What the source publishes

Labeler
A-S Medication Solutions
Active ingredients
levothyroxine sodium
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:50090-4799_f2ee3fc5-4e2b-4b13-bd7c-7cbbf520ac1f
{
  "name": "levothyroxine sodium",
  "splId": "f2ee3fc5-4e2b-4b13-bd7c-7cbbf520ac1f",
  "labels": [
    {
      "setId": "8f7dc71e-4a48-4ba5-945b-f340ff51636e",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f7dc71e-4a48-4ba5-945b-f340ff51636e",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8f7dc71e-4a48-4ba5-945b-f340ff51636e"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "A-S Medication Solutions",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET in 1 BOTTLE (50090-4799-0)",
      "package_ndc": "50090-4799-0",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20191216"
    },
    {
      "sample": false,
      "description": "90 TABLET in 1 BOTTLE (50090-4799-1)",
      "package_ndc": "50090-4799-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20191216"
    }
  ],
  "productId": "50090-4799_f2ee3fc5-4e2b-4b13-bd7c-7cbbf520ac1f",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "50090-4799",
  "deaSchedule": null,
  "genericName": "levothyroxine sodium",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LEVOTHYROXINE SODIUM",
      "strength": "125 ug/1"
    }
  ],
  "applicationNumber": "NDA021116",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20190507",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "9J765S329G"
    ],
    "rxcui": [
      "966224"
    ],
    "spl_set_id": [
      "8f7dc71e-4a48-4ba5-945b-f340ff51636e"
    ],
    "manufacturer_name": [
      "A-S Medication Solutions"
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:50090-4799_f2ee3fc5-4e2b-4b13-bd7c-7cbbf520ac1f"